Prognostic value of early CA19-9 response during chemotherapy in patients with advanced or recurrent biliary tract cancer 

2017 ◽  
Author(s):  
Naminatsu Takahara
Keyword(s):  
Biliary Tract ◽  
Biliary Tract Cancer ◽  
Prognostic Value ◽  
Tract Cancer

Prognostic value of carbohydrate antigen 19-9 in patients undergoing resection of biliary tract cancer

2017 ◽  
Vol 104 (3) ◽  
pp. 267-277 ◽  
Author(s):  
S. Yamashita ◽  
G. Passot ◽  
T. A. Aloia ◽  
Y. S. Chun ◽  
M. Javle ◽  
...  
Keyword(s):  
Biliary Tract ◽  
Biliary Tract Cancer ◽  
Prognostic Value ◽  
Carbohydrate Antigen ◽  
Tract Cancer

scholarly journals Prognostic Value of Intraoperative Peritoneal Cytology in Biliary Tract Cancer

2011 ◽  
Vol 44 (7) ◽  
pp. 803-808
Author(s):  
Kenya Yamanaka ◽  
Etsuro Hatano ◽  
Koji Kitamura ◽  
Kojiro Taura ◽  
Kentaro Yasuchika ◽  
...  
Keyword(s):  
Biliary Tract ◽  
Biliary Tract Cancer ◽  
Prognostic Value ◽  
Peritoneal Cytology ◽  
Tract Cancer

scholarly journals Prognostic value of the systemic immune-inflammation index in patients with biliary tract cancer: a systematic review and meta-analysis

2020 ◽  
Author(s):  
Faquan Zhou ◽  
Shi Chen ◽  
Yiquan Xiong ◽  
Xiaohui Yuan ◽  
Hongyu Sun ◽  
...  
Keyword(s):  
Biliary Tract ◽  
Biliary Tract Cancer ◽  
Prognostic Value ◽  
Treatment Strategies ◽  
Disease Free Survival ◽  
Cochrane Library ◽  
Cancer Specific Survival ◽  
Free Survival ◽  
Tract Cancer ◽  
Immune Inflammation

Abstract Background: The systemic immune-inflammation index (SII) has been found to predict outcomes in many tumors. The purpose of this study was to determine the prognostic value of SII in biliary tract cancer.Methods: We searched PubMed, EMBASE, Web of Science, Cochrane Library, CNKI, CBM, Wanfang and VIP databases from its inception until May 18, 2020. Pooled hazard ratio and 95% confidence interval were calculated to assess the prognostic role of SII in patients with BTC. The main outcomes included the overall survival, cancer-specific survival, disease-free survival and recurrence-free survival. Stata 12.0 was used for statistical analysis.Results: A total of 8 studies involving 2249 patients were eventually included. The results showed that elevated SII was significantly associated with poorer OS (HR=1.56, 95% CI: 1.23–1.99, P<0.001, I2 = 68.1%), poorer DFS/RFS (HR=1.42, 95%CI:1.09–1.84, P =0.009) and poorer CSS (HR =1.55, 95% CI: 1.09–2.21, P<0.014). Subgroup analysis further verified the above results. Conclusions: Higher SII is a predictor of poor prognosis in BTC patients. SII can serve as a useful prognostic indicator and help to evaluate the prognosis and formulate treatment strategies.Registered in PROSPERO: CRD42020184556

Chemotherapy for biliary tract cancer in Japan

2002 ◽  
Vol 29 (6U) ◽  
pp. 51-53 ◽  
Author(s):  
Takuji Okusaka
Keyword(s):  
Biliary Tract ◽  
Biliary Tract Cancer ◽  
Tract Cancer

EGFR and HER2 Expression in advanced Biliary Tract Cancer

2008 ◽  
Vol 46 (09) ◽  
Author(s):  
J Harder ◽  
O Waiz ◽  
M Geissler ◽  
HE Blum ◽  
A Schmitt-Gräff ◽  
...  
Keyword(s):  
Biliary Tract ◽  
Biliary Tract Cancer ◽  
Her2 Expression ◽  
Tract Cancer
Sign in / Sign up

Export Citation Format

Share Document